{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:04:10Z","timestamp":1787025850426,"version":"build-2736575974"},"reference-count":25,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.3201\/eid2004.131288","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T11:38:24Z","timestamp":1394624304000},"page":"612-619","source":"Crossref","is-referenced-by-count":18,"title":["Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991\u20132006"],"prefix":"10.3201","volume":"20","author":[{"given":"Harrell W.","family":"Chesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Kirkcaldy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Gift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Kwame","family":"Owusu-Edusei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard S.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2004.131288-201403121138-R1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2004.131288-201403121138-R2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","article-title":"The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.","volume":"40","author":"Owusu-Edusei","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2004.131288-201403121138-R3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00007435-197804000-00003","article-title":"Dynamics and control of the transmission of gonorrhea.","volume":"5","author":"Yorke","year":"1978","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2004.131288-201403121138-R4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00124784-199703000-00010","article-title":"Sexually transmitted disease control in the era of managed care: \u201cmagic bullet\u201d or \u201cshadow on the land\u201d?","volume":"3","author":"Chaulk","year":"1997","journal-title":"J Public Health Manag Pract"},{"key":"key-10.3201\/eid2004.131288-201403121138-R5","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1097\/01.olq.0000194575.79728.72","article-title":"Estimated effectiveness and cost-effectiveness of federally funded prevention efforts on gonorrhea rates in the United States, 1971\u20132003, under various assumptions about the impact of prevention funding.","volume":"33","author":"Chesson","year":"2006","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2004.131288-201403121138-R6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection.","volume":"366","author":"Bolan","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2004.131288-201403121138-R7","first-page":"873","article-title":"Cephalosporin susceptibility among Neisseria gonorrhoeae isolates\u2014United States, 2000\u20132010.","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2004.131288-201403121138-R8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11908-011-0169-9","article-title":"Gonococcal resistance: are cephalosporins next?","volume":"13","author":"Kirkcaldy","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"key-10.3201\/eid2004.131288-201403121138-R9","first-page":"332","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2004.131288-201403121138-R10","first-page":"590","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2004.131288-201403121138-R11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.1990.03450110059027","article-title":"National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.","volume":"264","author":"Schwarcz","year":"1990","journal-title":"JAMA"},{"key":"key-10.3201\/eid2004.131288-201403121138-R12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005\u20132010.","volume":"158","author":"Kirkcaldy","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2004.131288-201403121138-R13","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2011. Atlanta: The Centers; 2012."},{"key":"key-10.3201\/eid2004.131288-201403121138-R14","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/OLQ.0b013e31818d3cad","article-title":"Social determinants and sexually transmitted disease disparities.","volume":"35","author":"Hogben","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2004.131288-201403121138-R15","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.socscimed.2008.09.049","article-title":"Examining the impact of federally-funded syphilis elimination activities in the USA.","volume":"67","author":"Chesson","year":"2008","journal-title":"Soc Sci Med"},{"key":"key-10.3201\/eid2004.131288-201403121138-R16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1071\/SH13006","article-title":"Violent crime rates as a proxy for social determinants of STD rates: the consistent state-level correlation between violent crime and reported STDs in the United States, 1981\u20132010.","volume":"10","author":"Chesson","year":"2013","journal-title":"Sex Health"},{"key":"key-10.3201\/eid2004.131288-201403121138-R17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/OLQ.0b013e3181b6ac93","article-title":"Using spatial regression methods to examine the association between county-level racial\/ethnic composition and reported cases of Chlamydia and gonorrhea: an illustration with data from the state of Texas.","volume":"36","author":"Owusu-Edusei","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2004.131288-201403121138-R18","unstructured":"Estima. RATS version 8 user\u2019s guide. Evanston (IL): Estima; 2010."},{"key":"key-10.3201\/eid2004.131288-201403121138-R19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2307\/1912791","article-title":"Investigating causal relations by econometric models and cross-spectral methods.","volume":"37","author":"Granger","year":"1969","journal-title":"Econometrica"},{"key":"key-10.3201\/eid2004.131288-201403121138-R20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/infdis\/jis277","article-title":"Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.","volume":"205","author":"Kunz","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2004.131288-201403121138-R21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2958.1994.tb01297.x","article-title":"Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.","volume":"14","author":"Belland","year":"1994","journal-title":"Mol Microbiol"},{"key":"key-10.3201\/eid2004.131288-201403121138-R22","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone.","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131288-201403121138-R23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2004.131288-201403121138-R24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/sextrans-2011-050049","article-title":"Core groups, antimicrobial resistance and rebound in gonorrhoea in North America.","volume":"88","author":"Chan","year":"2012","journal-title":"Sex Transm Infect"},{"key":"key-10.3201\/eid2004.131288-201403121138-R25","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1136\/sti.78.suppl_1.i20","article-title":"The impact of the phase of an epidemic of sexually transmitted infection on the evolution of the organism.","volume":"78","author":"Turner","year":"2002","journal-title":"Sex Transm Infect"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/20\/4\/13-1288_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T23:25:44Z","timestamp":1733268344000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/20\/4\/13-1288_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2004.131288","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}